Glaxo Reports Q4 Earnings: GSK Plc (GSK) Surpasses Wall Street Expectations

[Para 1: The Lead] GSK plc (GSK) announced its Q4 earnings of $846 million, surpassing Wall Street expectations. Per share, the company reported net income of $0.42. Adjusted for non-recurring costs, earnings were $0.68 per share, exceeding forecasts by $0.04. Revenue of $11.46 billion also exceeded Street estimates of $11.19 billion. [Para 2-3: Supporting details & Context] For the fiscal year, GSK reported a profit of $7.54 billion, or $3.72 per share, and revenue of $43.07 billion. The company's strong performance is attributed to robust sales in its pharmaceuticals and vaccines segments. GSK's strategic focus on innovation and cost efficiency has contributed to its financial success. Shares of GSK closed at $65.25 on the New York Stock Exchange.